IN VIVO MODEL EVALUATION FOR PRECLINICAL DRUG DEVELOPMENT

In vivo assays are essential tools for preclinical drug development, facilitating researchers to determine the efficacy and safety of novel therapeutics in a living organism. Choosing the appropriate model is vital to ensure relevant preclinical findings. This involves a thorough understanding of the disease being studied, as well as the limitation